Reed Elsevier NV (ENL.N)

ENL.N on New York Stock Exchange

49.38USD
17 Apr 2015
Change (% chg)

$-0.70 (-1.40%)
Prev Close
$50.08
Open
$49.55
Day's High
$49.64
Day's Low
$49.16
Volume
18,298
Avg. Vol
22,606
52-wk High
$51.81
52-wk Low
$40.52

ENL.N

Chart for ENL.N

About

Reed Elsevier NV is a Netherlands-based company holding shares in RELX Group plc. RELX Group plc is a global provider of information solutions for professional customers across industries. The Company operates in four market segments: Scientific, Technical & Medical, providing information and tools to help customers improve... (more)

Overall

Beta: 1.19
Market Cap(Mil.): $17,163.10
Shares Outstanding(Mil.): 348.58
Dividend: 0.98
Yield (%): 2.79

Financials

  ENL.N Industry Sector
P/E (TTM): 27.35 21.70 28.71
EPS (TTM): 1.81 -- --
ROI: 42.61 9.48 5.29
ROE: 42.39 14.95 8.20
Search Stocks

Correct: Fitch Downgrades Reed Elsevier to 'BBB+'; Outlook Stable

(The following statement was released by the rating agency) LONDON, April 09 (Fitch) This announcement corrects the version published on 2 April 2015 to include the Elsevier Finance SA senior unsecured notes issued by ELM BV as well as by Aquarius + Investments PLC. Fitch Ratings has downgraded Reed Elsevier PLC's and Reed Elsevier NV's (together, Reed) Long-term Issuer Default Ratings (IDR) to 'BBB+' from 'A-'. The Outlook is Stable. A full list of rating actions is available below. Reed's

09 Apr 2015

Fitch Downgrades Reed Elsevier to 'BBB+'; Outlook Stable

(The following statement was released by the rating agency) LONDON, April 02 (Fitch) Fitch Ratings has downgraded Reed Elsevier PLC's and Reed Elsevier NV's (together, Reed) Long-term Issuer Default Ratings (IDR) to 'BBB+' from 'A-'. The Outlook is Stable. A full list of rating actions is available below. Reed's core business portfolio continues to perform strongly and in line with Fitch's expectations. The downgrade in Reed's ratings is triggered by management's propensity to accept slig

02 Apr 2015

Reed's Risk boss reaps rewards from tackling online fraudsters

LONDON - The softly-spoken head of the Risk division at Reed Elsevier does not wish to thank the U.S. online fraudsters who have helped drive his unit's growth, but his investors may not be so bashful.

04 Mar 2015

Drops in RBS and RSA shares peg back UK's FTSE 100

LONDON, Feb 26 - Share price falls in publisher Reed Elsevier and financial firms Royal Bank of Scotland and RSA kept Britain's top equity index in check on Thursday, although the market remained near record highs.

26 Feb 2015

Drops in Reed and RBS peg back UK's FTSE 100

LONDON, Feb 26 - A fall in the shares of publisher Reed Elsevier and Royal Bank of Scotland held Britain's top equity index in check on Thursday, although the market remained near record highs hit this week.

26 Feb 2015

Britain's FTSE edges higher after StanChart announces new CEO

LONDON, Feb 26 - Britain's top share index edged higher on Thursday following a spate of mixed earnings reports, supported by the banking sector as the market welcomed the announcement of a new CEO of Standard Chartered.

26 Feb 2015

UPDATE 2-Reed to revamp under new name RELX after results underwhelm

LONDON, Feb 26 - Anglo Dutch publisher Reed Elsevier plans to rename itself RELX and simplify its structure into one unit to make it more transparent for investors in the latest stage of its transformation.

26 Feb 2015

BRIEF-Reed Elsevier FY underlying adjusted operating profit rises to 2.16 bln euros

* FY 2014 revenue 7.16 billion euros versus 7.12 billion euros year ago

26 Feb 2015

Reed plans 500 mln stg buyback, simplifying structure

LONDON, Feb 26 - Anglo Dutch publisher Reed Elsevier plans to return 500 million pounds ($777 million) to investors via a share buyback after reporting an as expected 3 percent rise in full-year underlying sales.

26 Feb 2015

BRIEF-Reed Elsevier division LexisNexis intends to buy Health Market Science

* Division LexisNexis Risk Solutions announced its intent to acquire Health Market Science (HMS)

13 Nov 2014

Competitors

Earnings vs. Estimates

Search Stocks